Table. 3.

Clinical manifestations in cases with respiratory virus infection

Group MPV ADV PIV1 PIV2 PIV3 PIV4 Flu A Flu B HRV A/B RSV A RSV B Entero Boca OC43 229E/NL63
Fever 48 (5.9) 152 (18.6) 75 (9.2) 6 (0.7) 66 (8.1) 4 (0.5) 24 (2.9) 33 (4.0) 130 (15.9) 95 (11.6) 68 (8.3) 5 (0.6) 11 (1.3) 62 (7.6) 38 (4.7)
Fever >5 d 9 (3.0) 80 (26.9) 37 (12.5) 2 (0.7) 30 (10.1) 3 (1.0) 6 (2.0) 7 (2.4) 64 (21.5) 20 (6.7) 8 (2.7) 3 (1.0) 3 (1.0) 17 (5.7) 8 (2.7)
Wheezing 9 (4.3) 21 (10.0) 18 (8.6) 1 (0.5) 12 (5.7) 2 (1.0) 6 (2.9) 6 (2.9) 40 (19.0) 30 (14.3) 42 (20.0) 0 (0.0) 4 (1.9) 13 (6.2) 6 (2.9)
Crackle 38 (6.7) 58 (10.2) 27 (4.8) 4 (0.7) 35 (6.2) 3 (0.5) 8 (1.4) 20 (3.5) 77 (13.6) 91 (16.0) 120 (21.1) 2 (0.4) 8 (1.4) 48 (8.5) 29 (5.1)

Values are presented as number (%).

MPV, human metapneumovirus; ADV, human adenovirus; PIV1, human parainfluenza virus 1; PIV2, human parainfluenza virus 2; PIV3, human parainfluenza virus 3; PIV4, human parainfluenza virus 4; Flu A, influenza A; Flu B, influenza B; HRV A/B, human rhinovirus A/B; RSV A, respiratory syncytial virus A; RSV B, respiratory syncytial virus B; Entero, enterovirus; Boca, human bocavirus; OC43, human coronavirus-OC43; 229E/NL63, human coronavirus-229E/NL63.

Korean J Fam Pract 2021;11:210~216 https://doi.org/10.21215/kjfp.2021.11.3.210
© KJFP